Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT02102113
EARLY_PHASE1

Probing the Cannabinoid System in Individuals With a Family History of Psychosis

Sponsor: Yale University

View on ClinicalTrials.gov

Summary

The overall purpose of this study is to determine whether a family history of psychosis is associated with an altered cannabinoid system. This will be tested by studying individuals with and without a family history of psychosis and comparing their responses to delta 9-tetrahydrocannabinol (THC), a probe of the cannabinoid system. We hypothesize, that compared to controls with no family history of psychoses, individuals with a family history of psychoses will have an altered response to THC.

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

21

Start Date

2014-01

Completion Date

2026-12

Last Updated

2025-06-10

Healthy Volunteers

Yes

Interventions

DRUG

Placebo

placebo

DRUG

Very Low Dose THC

Subjects will receive 0.010mg/kg.

DRUG

Low Dose THC

Subjects will receive 0.018 mg/kg over 20 minutes.

Locations (1)

VA Connecticut Healthcare System

West Haven, Connecticut, United States